Rallybio CORP DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
Rallybio Corporation seeks stockholder approval for a reverse stock split to maintain its Nasdaq listing and enhance stock marketability.
NASDAQ
Rallybio Corporation announces its 2025 Annual Meeting of Stockholders to be held virtually on May 13, 2025, with key proposals including the election of directors and ratification of the company's independent accounting firm.
NASDAQ
Rallybio Corporation announces its 2024 Annual Meeting of Stockholders to be held virtually on May 15, 2024, to elect directors and ratify the selection of its independent accounting firm.